Table 3.
Uptake of risk consultation appointments, breast cancer preventive medicines (BCPM) and additional mammography screening.
High | Mod | Ave | Low | Total | |
---|---|---|---|---|---|
N | 197 | 379 | 1389 | 498 | 2463 |
% | 8.00% | 15.40% | 56.40% | 20.20% | 100% |
Risk appointment | 80 | 68 | 1 | 0 | 149 |
% | 40.60% | 17.90% | 0.07% | 0.00% | 6.05% |
P value | P < 0.0001 | Reference | |||
BCPM | 62 | 43 | 0 | 0 | 105 |
% of all | 31.50% | 11.30% | 0.00% | 0.00% | 4.26% |
P value | P < 0.0001 | Reference | |||
% seen | 77.50% | 63.20% | 0.00% | 70.47% | |
Additional screening NHS | 46 | 11 | 57 | ||
Additional screening Private | 17 | 33 | 50 | ||
Total | 63 | 44 | 107 | ||
% uptake additional screening of those seen | 78.75% | 64.71% | 71.81% |